Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004.
Previous studies on the incidence of the various types of mucopolysaccharidoses (MPS) in different populations have shown considerable variation. However, information regarding the incidence of MPS in the Asian population is lacking. An epidemiological study of the MPS disorders in Taiwan using multiple ascertainment sources was undertaken, and incidences of different types of MPS during the period of 1984-2004 were estimated. We compared our data with previous reports in different populations. The combined birth incidence for all MPS cases was 2.04 per 100,000 live births. MPS II (Hunter syndrome) had the highest calculated birth incidence of 1.07 per 100,000 live births (2.05 per 100,000 male live births), comprising 52% of all MPS cases diagnosed. The birth incidences of MPS I (Hurler syndrome), III (Sanfilippo syndrome), IV (Morquio syndrome), and VI (Maroteaux-Lamy syndrome) were 0.11, 0.39, 0.33, and 0.14 per 100,000 live births, respectively, which accounted for 6%, 19%, 16%, and 7% of all MPS, respectively. No cases of MPS III D (Sanfilippo syndrome type D), MPS IV B (Morquio syndrome type B), MPS VII (Sly syndrome) or MPS IX were ascertained during the study period. Overall incidence of MPS in Taiwan was consistent with that reported in Western populations. However, in contrast to the higher incidence of MPS I in most Western populations, this study showed a higher incidence of MPS II in Taiwan. It remains to be investigated whether this discrepancy is attributed to the under-diagnosis of MPS I in Taiwan or to ethnic differences.
Lin
Hsiang-Yu
HY
Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
Lin
Shuan-Pei
SP
Chuang
Chih-Kuang
CK
Niu
Dau-Ming
DM
Chen
Ming-Ren
MR
Tsai
Fuu-Jen
FJ
Chao
Mei-Chyn
MC
Chiu
Pao-Ching
PC
Lin
Shio-Jean
SJ
Tsai
Li-Ping
LP
Hwu
Wuh-Liang
WL
Lin
Ju-Li
JL
D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D009083:Mucopolysaccharidoses / Q000453:epidemiology*; D013624:Taiwan / Q000453:epidemiology